Published in J Biol Chem on July 05, 1985
Demonstration of ferric L-parabactin-binding activity in the outer membrane of Paracoccus denitrificans. J Bacteriol (1988) 0.84
Increase in spermine content coordinated with siderophore production in Paracoccus denitrificans. J Bacteriol (1991) 0.82
Spoxazomicin D and Oxachelin C, Potent Neuroprotective Carboxamides from the Appalachian Coal Fire-Associated Isolate Streptomyces sp. RM-14-6. J Nat Prod (2016) 0.81
Kinetics of iron acquisition from ferric siderophores by Paracoccus denitrificans. J Bacteriol (1990) 0.81
Stereospecificity of the siderophore pyochelin outer membrane transporters in fluorescent pseudomonads. J Biol Chem (2009) 0.78
Desferrithiocin: a search for clinically effective iron chelators. J Med Chem (2014) 0.76
Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res (1991) 1.29
Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J Biol Chem (1993) 1.25
Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators. Biochem Biophys Res Commun (1984) 1.24
Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res (1989) 1.21
Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation. Science (1983) 1.19
Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth. Cancer Res (1987) 1.18
Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells. Cancer Res (1985) 1.17
Differential response to treatment with the bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in culture. Cancer Res (1989) 1.11
Polyamine and polyamine analog regulation of spermidine/spermine N1-acetyltransferase in MALME-3M human melanoma cells. J Biol Chem (1993) 1.10
Steady-state messenger RNA and activity correlates with sensitivity to N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res (1992) 1.09
Control of ornithine decarboxylase activity in alpha-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. J Biol Chem (1988) 1.07
Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine. Biochem J (1987) 1.06
Enzyme regulation as an approach to interference with polyamine biosynthesis--an alternative to enzyme inhibition. Adv Enzyme Regul (1988) 1.06
Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Cancer Res (1999) 1.05
Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Clin Cancer Res (1995) 1.05
Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res (1993) 0.99
Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res (1984) 0.99
Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochem Pharmacol (1989) 0.98
Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators. J Med Chem (1991) 0.96
Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res (1992) 0.96
Structural basis for differential induction of spermidine/spermine N1-acetyltransferase activity by novel spermine analogs. Mol Pharmacol (1997) 0.96
Correlation between the effects of polyamine analogues on DNA conformation and cell growth. Cancer Res (1989) 0.95
Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. Cancer Res (1997) 0.94
Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol (1997) 0.94
Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N1, N12-bis(ethyl)spermine. Cancer Res (1993) 0.93
Structural determinants of spermidine-DNA interactions. Biopolymers (1987) 0.92
Treatment with alpha-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells. J Cell Physiol (1984) 0.92
Biological properties of N4-spermidine derivatives and their potential in anticancer chemotherapy. Cancer Res (1982) 0.89
Influence of iron on in vivo proliferation and lethality of L1210 cells. J Nutr (1985) 0.88
Characterization of human spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells. Arch Biochem Biophys (1991) 0.88
Combined regulation of ornithine and S-adenosylmethionine decarboxylases by spermine and the spermine analogue N1 N12-bis(ethyl)spermine. Biochem J (1990) 0.88
Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. Anticancer Res (1992) 0.87
Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells. Cancer Res (1989) 0.86
Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell lines. Cancer Chemother Pharmacol (1992) 0.85
Investigations of the mechanism by which mammalian cell growth is inhibited by N1N12-bis(ethyl)spermine. Biochem J (1993) 0.85
Regulation of polyamine transport by polyamines and polyamine analogs. J Cell Physiol (1993) 0.85
Human prostatic carcinoma cell lines display altered regulation of polyamine transport in response to polyamine analogs and inhibitors. Prostate (1998) 0.85
Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther (1998) 0.85
Effect of N1,N12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J Biol Chem (1989) 0.84
Demonstration of ferric L-parabactin-binding activity in the outer membrane of Paracoccus denitrificans. J Bacteriol (1988) 0.84
Cholestatriene and ergostatetraene as in vivo and in vitro membrane and lipoprotein probes. J Lipid Res (1982) 0.84
Synthesis, absorption, and toxicity of N1,N8-bis(2,3-dihydroxybenzoyl)spermidine, a potent iron chelator. J Med Chem (1980) 0.83
Modulation of polyamine biosynthesis and transport by oncogene transfection. Biochem Biophys Res Commun (1988) 0.83
Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models. Cancer Chemother Pharmacol (1992) 0.83
Monophosphoryl lipid A protects adult rat cardiac myocytes with induction of the 72-kD heat shock protein: a cellular model of pharmacologic preconditioning. J Mol Cell Cardiol (1997) 0.82
Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs. Pharmacology (1995) 0.82
Selective regulation of S-adenosylmethionine decarboxylase activity by the spermine analogue 6-spermyne. Biochem J (1988) 0.82
Effect of N1,N14-bis(ethyl)homospermine on the growth of U-87 MG and SF-126 human brain tumor cells. Cancer Res (1990) 0.82
Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis. J Cardiovasc Pharmacol (1998) 0.81
Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II. Cancer Res (1985) 0.81
KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A. Am J Physiol (1996) 0.80
Induction of spermidine/spermine N1-acetyltransferase activity in Chinese-hamster ovary cells by N1N11-bis(ethyl)norspermine (corrected) and related compounds. Biochem J (1990) 0.80
Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium? Ann N Y Acad Sci (1999) 0.80
Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes? Am J Physiol (1996) 0.79
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel. Circulation (1999) 0.79
Effects of diethyl spermine analogues in human bladder cancer cell lines in culture. J Urol (1993) 0.79
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting. J Med Chem (1989) 0.78
Design and testing of novel cytotoxic polyamine analogues. Cancer Res (1994) 0.78
Regulation of polyamine biosynthetic activity by spermidine and spermine analogs--a novel antiproliferative strategy. Adv Exp Med Biol (1988) 0.78
Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis? J Cardiovasc Pharmacol (2000) 0.78
Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. Cancer Res (1998) 0.78
Selective cellular depletion of mitochondrial DNA by the polyamine analog N1,N12-bis(ethyl)spermine and its relationship to polyamine structure and function. Mol Pharmacol (1991) 0.78
Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia. Ann N Y Acad Sci (1999) 0.78
Boundary conditions for the Hildebrand-Benesi equation. Anal Biochem (1978) 0.77
Effects of the Vibrio cholerae siderophore vibriobactin on the growth characteristics of L1210 cells. Biochem Biophys Res Commun (1986) 0.77
Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia. Drugs Exp Clin Res (1998) 0.76
Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein. Mol Cell Biochem (1996) 0.76
Bacteriostatic and fungostatic action of catecholamide iron chelators. Antimicrob Agents Chemother (1983) 0.76
Monophosphoryl lipid A induces pharmacologic 'preconditioning' in rabbit hearts without concomitant expression of 70-kDa heat shock protein. Mol Cell Biochem (1996) 0.76
Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation. Ann Thorac Surg (2000) 0.76
Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). J Mol Cell Cardiol (1996) 0.76
Pharmacologic preconditioning with monophosphoryl lipid A is abolished by 5-hydroxydecanoate, a specific inhibitor of the K(ATP) channel. J Cardiovasc Pharmacol (1998) 0.76
Stability of cimetidine hydrochloride in admixtures after microwave thawing. Am J Hosp Pharm (1983) 0.75
Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine. Cancer Res (1994) 0.75
Sulfisoxazole in human milk. J Pediatr (1981) 0.75
Tyrosine kinase signaling in action potential shortening and expression of HSP72 in late preconditioning. Am J Physiol Heart Circ Physiol (2000) 0.75
Interest among Florida hospital pharmacists in microwave thawing of frozen intravenous medications. Am J Hosp Pharm (1981) 0.75
Nitroglycerin intravenous infusion. Drug Intell Clin Pharm (1982) 0.75
Treatment of hypercalcemia. Drug Intell Clin Pharm (1983) 0.75
Radiopotentiation of human brain tumor cells by the spermine analog N1,N14-bis(ethyl)homospermine. Int J Radiat Oncol Biol Phys (1994) 0.75
Disparate effects of preconditioning and MLA on 5'-NT and adenosine levels during coronary occlusion. Am J Physiol (1997) 0.75